Preview

Astrazeneca Strategic Business Analysis

Powerful Essays
Open Document
Open Document
2438 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Astrazeneca Strategic Business Analysis
AstraZeneca
Strategic Business Analysis - Group Case Study

Case Abstract
Introduction AstraZeneca PLC (AstraZeneca, AZN:NYSE, AZN:LSE) is one of the largest pharmaceutical companies in the world. It was formed in 1999 from the merger of Sweden’s Astra AB and UK’s Zeneca Group plc. Core Activities AstraZeneca is engaged in the discovery, development, manufacturing and marketing of prescription pharmaceuticals and biological products for important areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. One of the key benefits of the merger between Astra and Zeneca is seen as their portfolio of new products in development: AstraZeneca call this their 'product pipeline'. – Cardiovascular product pipeline includes Saxagliptin, Atherosclerosis/dyslipidaemia, Thrombosis and Atrial fibrillation. Gastrointestinal pipeline includes life cycle management initiatives. AstraZeneca's Infection pipeline MedImmune and Dedicated tuberculosis (TB) research. Oncology product pipeline includes Zactima (vandetanib), Zactima (vandetanib), ZD4054 and MedImmune. Dapagliflozin,

– –



Products The company's product portfolio includes many world leaders and a number of high potential growth products: Arimidex (cancer), Crestor (cardiovascular), Nexium (gastrointestinal disease), Seroquel (schizophrenia) and Symbicort (asthma and chronic obstructive pulmonary disease). Profile – Active in over 100 countries with a growing presence in important emerging markets including China; corporate office in London, UK; and major R&D sites in Sweden, the UK and the US. It employs over 65,000 people (51% in Europe, 32% in the Americas and 17% in Asia, Africa and Australasia).



Compiled by Rexford Sam

Group Case Study – Strategic Business Analysis (Re-Sit 2010)

1

– – –

Sales in 2008 totalled $31.6 billion. R&D investment totalled over $5 billion. It has around 12,000 people in our R&D organisation and 17



References: Compiled by Rexford Sam Group Case Study – Strategic Business Analysis (Re-Sit 2010) Compiled by Rexford Sam Group Case Study – Strategic Business Analysis (Re-Sit 2010) 9 E-version of annual reports Marks & Spencer, 2004. Annual report 2003-2004. [Online]. Available at: http://www-marks-andspencer.co.uk/corporate/annual2003/ [accessed 4 June 2005] Compiled by Rexford Sam Group Case Study – Strategic Business Analysis (Re-Sit 2010) 2

You May Also Find These Documents Helpful

  • Powerful Essays

    United Airlines

    • 23413 Words
    • 94 Pages

    Comprehensive Term Project United Airlines [pic] Prepared By: Presented to: Jeffrey R. Nystrom Management 4500 Business Policy and Strategic Management November 18, 2008 Table of Contents SECTION 1: CASE STUDY 1 1.1 Background / History 1 1.2 Organizational Mission 1 1.3 External Environment 2 1.4 Internal State of Affairs 4 1.5 Generic Strategy 5 1.6 Long-Term Objectives 5 1.7 Grand Strategies 5 1.8 Short-Term Objectives 6 1.9 Functional Tactics 7 1.10 Strategic Execution 8 1.11 Executive Bonus Compensation Plans 8 1.12 Current and Historical Culture and Structure 9 1.13 Strategic Controls 10 1.14 Innovation and Entrepreneurship 11 SECTION 2: IDENTIFICATION OF KEY STRATEGIC ISSUES 12 Culture: 12 Market share: 12 Economy: 12 SECTION 3: ANALYSIS AND EVALUATION 13 3.1 External Environment 13 3.2 Internal Analysis 16 3.3 SWOT Analysis 18 3.4 Organizational Mission 18 3.5 Generic Strategy 19 3.6 Long-Term Objectives 20 3.7 Grand Strategies 21 3.8 Short-Term Objectives 22 3.9 Functional Tactics 24 3.10 Strategic Execution 25 3.11 Executive Bonus Compensation Plans 25 3.12 Company Culture, Structure, and Leadership 26 3.13 Strategic Control 27 3.14 Innovation and Entrepreneurship 28 SECTION 4: RECOMMENDATIONS 29 4.1 External Environment – Opportunities and Threats 29 4.2 Internal Environment – Strengths and Weaknesses 30 4.3 Organizational Mission 30 4.4 Generic Strategy 31 4.5 Long-Term Objectives 33 4.6 Grand Strategies 33 4.7 Short-Term Objectives and Action Plans 35 4.8 Strategic Execution 35 4.9 Executive Bonus Compensation Plans 36 4.10 Strategy Implementation 37 4.11 Strategic and Operational Controls 40 4.12 Innovation and Entrepreneurship 42 Section 1 Appendices 43 Appendix 1A - United Airlines Timeline 43 Appendix 1B - Corporate Responsibility Statement 45…

    • 23413 Words
    • 94 Pages
    Powerful Essays
  • Powerful Essays

    The principle products are neurosciences type, which its largest selling product currently is Zyprexa for the treatment of schizophrenia, “bipolar mania and bipolar maintenance.” Recently in 2004 it released Cymbalta, a major depressive disorder treatment drug projecting sales to carry the company’s growth in stead of Zyprexa. Other lesser branches of research also include oncology products such as Gemzar, and Cardiovascular agents including ReoPro.…

    • 959 Words
    • 4 Pages
    Powerful Essays
  • Best Essays

    References: Marks & Spencers Press Release, 2010. MARKS AND SPENCER GROUP PLC QUARTER 2 2010/11 – TRADING STATEMENT [Online]…

    • 2705 Words
    • 11 Pages
    Best Essays
  • Better Essays

    Pharmanet-i3, a subsidiary of inVentive Health, is a world leading clinical research organization committed to the advancement of health around the world. The mission of Pharmanet-i3 is to be a strategic partner to companies that develop therapeutic drugs, and aim to bring drugs to the public that treat disease and improve the quality of life. The company will operate within the industry’s highest quality standards with uncompromising integrity, ethics, and respect for employees, study participants, the environment, and the communities in which the employees live and work. Shareholders can expect superior returns through the implementation of a successful growth strategy (Pharmanet-I3, n.d.).…

    • 1342 Words
    • 6 Pages
    Better Essays
  • Powerful Essays

    M&S AND RIVER ISLAND

    • 2821 Words
    • 12 Pages

    Corporate.marksandspencer.com. (2013) 'Reports & publications 2013 ' [online] Available at: http://corporate.marksandspencer.com/investors/reports_publications/2012_2 [Accessed: 2 Apr 2014].…

    • 2821 Words
    • 12 Pages
    Powerful Essays
  • Good Essays

    Many of us have heard of AstraZenca on television commercials but have not really paid too much attention. A few brand named medicines are Crestor, for cardiac issues, and Nexium, for gastrointestinal issues, Atenolol, Pulmicort, Seroquel, Symbicort, and Zestril. AstraZeneca is a global company that is regulated by every country it works in. Maintaining a high ethical platform for the company and the employees is vital to the continued success of AstraZeneca.…

    • 938 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    KEL531 PDF ENG

    • 6147 Words
    • 32 Pages

    In 2010 Amgen had ten drugs approved for sales in the United States. The most important of…

    • 6147 Words
    • 32 Pages
    Powerful Essays
  • Best Essays

    Pfizer Industry Review

    • 4325 Words
    • 18 Pages

    The pharmaceutical industry began in the early 1800’s when several chemical companies were founded in Philadelphia, marking the beginning of our current pharmaceutical manufacturing industry (Pfizer, 2008a). Founded in 1849, Pfizer has grown into a multibillion-dollar corporation by providing many of the highest quality drugs available today (Pfizer, 2007). However, many factors impact the continued success of Pfizer and the pharmaceutical industry in general. After reviewing these factors, it is our recommendation that Pfizer focus on short-term consolidation and long-term global expansion into emerging markets while focusing research and development efforts in the biotech sector.…

    • 4325 Words
    • 18 Pages
    Best Essays
  • Good Essays

    Medmmune Case Study Essay

    • 678 Words
    • 3 Pages

    MedImmune is a biotechnology company based in Gaithersbug, Maryland. Currently the company has five products on the market: Synagis, CytoGam, RespiGam, Ethyol, and NeuTrexin. These medications target small markets of patients with auto-immune disorders, treating either respiratory illnesses or cancer. In addition, the company has several medications currently under development, including one in the preclinical phase, three in phase I of clinical trials, three in phase II trials, four in phase III, and one in phase IV efficacy trials. Due to the nature of the medical industry and regulations on testing and approval for drugs, it could be several years before any of these medications currently under development could obtain approval and be marketed.…

    • 678 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Merck Business Analysis

    • 1943 Words
    • 8 Pages

    The global pharmaceutical market is likely to undergo a wide variety of changes with new competition arising in India, China, Malaysia, South Korea, and Indonesia. This new competition has a growing economy and has made a difference between the product cost and disposable income of consumers. According to NASDAQ (2011),“ Global pharmaceutical market sales are expected to grow at a 4-7% through the year 2013 largely being driven by the growing access to health care in emerging economic regions” (para. 2-5). Short-term growth within this area is stimulated by the United States market, as it continues to be the largest pharmaceutical market in the world. A focal point on research and development in special drugs and generic drugs will remain a strong means to meet 2011 goals of earning $315 billion dollar in sales within the United States.…

    • 1943 Words
    • 8 Pages
    Powerful Essays
  • Best Essays

    Astrazeneca-report

    • 4092 Words
    • 17 Pages

    AstraZeneca is a global biopharmaceutical company that was created when the Swedish company ‘Astra’ and the British company ‘Zeneca Group’ merged in 1999 (Jerrang & Goldberg, 2011). Since then, it has immersed itself into the competitive pharmaceutical market and become a very successful business that specialises in the “research, development, manufacture and marketing of prescription pharmaceuticals” (AstraZeneca, 2011).…

    • 4092 Words
    • 17 Pages
    Best Essays
  • Powerful Essays

    Company report review Marks and Spencer Maplecroft Maplecroft House Bath Road Bradford on Avon BA15 2PE United Kingdom T +44 (0) 1225 863 882 F +44 (0) 1225 864 950 http://www.maplecroft.net Corporate Social Responsibility Report 2005 Presented by: Maplecroft Company report review Marks and Spencer – CSR Report 2005 Contents 1 Introduction ............................................................................................................................................... 3 1.1 Company background....................................................................................................................... 3 1.2 CSR rationale.................................................................................................................................... 3 1.3 Key issues......................................................................................................................................... 3 2 Key activities and impacts......................................................................................................................... 3 2.1 Business ethics ................................................................................................................................. 3 2.1.1 Governance........................................................................................................................…

    • 2504 Words
    • 13 Pages
    Powerful Essays
  • Good Essays

    The firm conducts research and produces pharmaceutical products medicines in fields of seven therapeutic areas: cardiovascular diseases, oncology, internal medicine, metabolic disorders (especially diabetes), central nervous system disorders and thrombosis. Sanofi- Aventis is a global pharmaceutical group focused on the research, development, manufacture and marketing of healthcare products. It offers Rx (prescription) drugs, OTC/OTX (over-the counter/combined OTC and Rx drugs), generics, vaccines and animal health products in about 100 counties across the world. The main strategy of the company to achieve their goals is based on their three priorities. They…

    • 4174 Words
    • 17 Pages
    Good Essays
  • Powerful Essays

    Sanofi-Aventis Acquisition

    • 5913 Words
    • 19 Pages

    Bibliography: Cleaves, K., Thayer A., (August 2004). Warning, merge with care: Sanofi-Aventis. Modern Drug Discovery. Retreived on June 6, 2014 from http://pubs.acs.org/subscribe/archive/mdd/v07/i08/pdf/804business2.pdf…

    • 5913 Words
    • 19 Pages
    Powerful Essays
  • Powerful Essays

    We produce and market 'branded generics' for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets. We also manufacture active pharmaceutical ingredients and intravenous fluids and contract manufacture for major international brands of leading multinational companies. We partner our activities to the…

    • 9622 Words
    • 50 Pages
    Powerful Essays

Related Topics